Skip to main content
See every side of every news story
Published loading...Updated

Is Pfizer Stock the Only Big Pharma Name I'd Buy and Hold Through Any Market Crash?

Summary by The Motley Fool
Key PointsPfizer has reached a transition point following declines of some of its biggest blockbusters.The pharma giant is paving the way to growth through new products and acquisitions.10 stocks we like better than Pfizer › Pfizer (NYSE: PFE) is the name behind one of the world's top-selling products: the coronavirus vaccine. It brought in more than $37 billion at its peak in 2022 and helped the company achieve $100 billion in annual revenue. S…

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Friday, February 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal